Santi Nolasco

Personal favourite advice from the inspiring @asthmalunguk Summer Conference: @ProfJDChalmers "Don't let things stop you" - the clue is in the photo 😆 @alukresearch #AsthmaLungUK #Inspiration #RespIsBest

Phenotyping the responses to systemic #corticosteroids in the managementof #asthma #attacks (#PRISMA). @ERSpublications @USherbrooke @PoumonQc @FRQS1 @HUSI_Investiga publications.ersnet.org/content/erj/65… Are #corticosteroids needed for all #asthma #exacerbations? publications.ersnet.org/content/erj/65…

Our paper "Clinical Remission by a Comprehensive Severe Asthma Management Strategy Guided by Airway Inflammometry & Bioimaging" is now published in the @ATSBlueEditor #BlueJournal! 🔗doi.org/10.1164/rccm.2… #SevereAsthma #AsthmaResearch #PersonalizedMedicine @atscommunity

@nolascos91 gave an amazing conference on Clinical #Remission by a Comprehensive Severe #Asthma Management Strategy Guided by Airway Inflammometry and Bioimaging, thanks for your generosity and for sharing all your experiencia with us! 🤩✨🫁 Great learnings!

Clinical #Remission by a Comprehensive Severe #Asthma Management Strategy Guided by Airway Inflammometry and Bioimaging @UniversidadCES @CardioVid @Majito25MD @asoneumocito142 @nolascos91 meet.google.com/yxs-negw-djh

The eosinophil evolutionary tree presented by Steve Ackerman 😃 @EosinophilSoc #IES25

The new @EuroRespSoc Handbook is incoming! Edited by Paolo Palange and Anita Simonds, with Associate Editors Stefano Aliberti, Najib M. Rahman and Christian Karagiannidis it brings together a worldwide group of expert authors...(1/2)

INSIDE LOOK 👀 Read from the upcoming issue (July 8): Original research indicates that clinical remission is a realistic goal, sustainable up to two years in around one-third of patients w/ severe eosinophilic #asthma receiving benralizumab. hubs.la/Q03vrqbf0 #JournalCHEST

How should we integrate #telemedicine in #HMV into daily practice? The new @EuroRespSoc guidelines on telemedicine in HMV offer practical answers and expert recommendations to guide clinical implementation. @ERSAssembly2 @ERSpublications publications.ersnet.org/content/erj/ea…

The proposed #ERS/#ATS 2022 guidelines appear to underestimate the prevalence of #spirometry response to #bronchodilator and individuals not identified have higher respiratory burden, potentially leading to additional testing and delayed #asthma diagnosis. interasma.org/2025/06/19/eva…

Was not prepared for the graphical abstract

The day you'll bury your dad is the day you'll realize you lost the only man who genuinely wants you to win.

Find a mentor who wants to push you forwards

Patients with bronchiectasis treated with long-term high-flow nasal therapy showed a significant improvement in mucus plug score. Check out our new study on ERJOR: bit.ly/3NV39zI @ERSpublications @Crimillina

Look what just appeared online as part of the ERS congress programme for September 👀 Can't wait to share the NEW ERS Bronchiectasis Guidelines 2025! Join us in Amsterdam #bronchiectasis #Guidelines @AlibertiStefano @EMBARCnetwork

What's the meaning of the glucose spikes after eating? A new @NatureMedicine study finds people have different food triggers and some connect with insulin resistance, along with ways to mitigate spikes nature.com/articles/s4159…

Clinical and Biological Features of a Thickened Basement Membrane Zone in Asthma atsjournals.org/doi/abs/10.116… 🔗

Channeling Relaxation through Multiple Means: TMEM16A Antagonism for Asthma @atscommunity 🔓 Open Access 🔗 atsjournals.org/doi/full/10.11…

Therapies that target IL-5 or its receptor IL-5α are used to treat patients with severe eosinophilic asthma. Do anti-IL-5 and anti IL-5α biological therapies affect mast cells and their progenitors, potentially impacting asthma outcomes? bit.ly/3Y3meoK

The immunology of asthma and chronic rhinosinusitis bit.ly/3Rw9ymM